Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study
Isabel Weigand, Barbara Altieri, Amanda Meneses Ferreira Lacombe, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 8, pp. 2642-2653
Open Access | Times Cited: 21

Showing 21 citing articles:

Next-generation therapies for adrenocortical carcinoma
Barbara Altieri, Cristina L. Ronchi, Matthias Kroiß, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2020) Vol. 34, Iss. 3, pp. 101434-101434
Closed Access | Times Cited: 82
The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives
Maja Mizdrak, Tina Tičinović Kurir, Joško Božić
Biomedicines (2021) Vol. 9, Iss. 2, pp. 174-174
Open Access | Times Cited: 34
Pharmacogenetics of Drugs Used in the Treatment of Cancers
Beata Franczyk, Jacek Rysz, Anna Gluba-Brzózka
Genes (2022) Vol. 13, Iss. 2, pp. 311-311
Open Access | Times Cited: 23
Mitotane activates ATF4/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells
Aurora Schiavon, L. Saba, Carlotta Evaristo, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117917-117917
Closed Access
Medical Approaches in Adrenocortical Carcinoma
Rosa Maria Paragliola, Andrea Corsello, Pietro Locantore, et al.
Biomedicines (2020) Vol. 8, Iss. 12, pp. 551-551
Open Access | Times Cited: 26
Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro Studies
Marco Lo Iacono, Soraya Puglisi, Paola Perotti, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5255-5255
Open Access | Times Cited: 22
The Challenging Pharmacokinetics of Mitotane: An Old Drug in Need of New Packaging
Malik Salman Haider, Taufiq Ahmad, Jürgen Gröll, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2021) Vol. 46, Iss. 5, pp. 575-593
Open Access | Times Cited: 19
Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options
Ruaa Al-Ward, Celeste Zsembery, Mouhammed Amir Habra
Endocrine Oncology (2022) Vol. 2, Iss. 1, pp. R90-R101
Open Access | Times Cited: 13
Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma
Barbara Altieri, Otilia Kimpel, Felix Megerle, et al.
European Journal of Endocrinology (2024) Vol. 190, Iss. 2, pp. 139-150
Open Access | Times Cited: 2
Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics
Jie Zhang, Luming Wu, Tingwei Su, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma
Fabiano Flauto, Maria Cristina De Martino, Chiara Vitiello, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4061-4061
Open Access | Times Cited: 2
High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer
Carolin Eckhardt, Iuliu Sbiera, Markus Krebs, et al.
Prostate Cancer and Prostatic Diseases (2021) Vol. 25, Iss. 3, pp. 484-490
Open Access | Times Cited: 16
Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning
André Marquardt, Laura‐Sophie Landwehr, Cristina L. Ronchi, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4671-4671
Open Access | Times Cited: 16
SOAT1 is a new prognostic factor of colorectal cancer
Xinchun Wang, Lin-Ming Luo, Taosheng Huang, et al.
Irish Journal of Medical Science (1971 -) (2021) Vol. 191, Iss. 4, pp. 1549-1554
Closed Access | Times Cited: 9
Medical management of adrenocortical carcinoma: Current recommendations, new therapeutic options and future perspectives
Vincent Amodru, Marie-Eve Garcia, Rossella Libé, et al.
Annales d Endocrinologie (2020) Vol. 82, Iss. 1, pp. 52-58
Open Access | Times Cited: 6
Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall Survival
S. Hescot, Matthieu Faron, Manal Kordahi, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2225-2225
Open Access | Times Cited: 4
Morphological predictors of the efficacy of mitotane therapy in adrenocortical cancer
A. V. Tkachuk, D. G. Beltsevich, E. E. Porubayeva, et al.
Problems of Endocrinology (2023) Vol. 68, Iss. 6, pp. 76-88
Open Access | Times Cited: 2
Mitotane treatment in adrenocortical carcinoma: mechanisms of action and predictive markers of response to therapy
Barbara Altieri, Enzo Lalli, Antongiulio Faggiano
Minerva Endocrinology (2021) Vol. 47, Iss. 2
Closed Access | Times Cited: 5
Characterization of hyperlipidemia secondary to mitotane in adrenocortical carcinoma
Nadia Gagnon, Sophie Bernard, Martine Paquette, et al.
Endocrine Oncology (2022) Vol. 2, Iss. 1, pp. 1-8
Open Access | Times Cited: 3
Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive Markers
Judit Tőke, Zsuzsanna Jakab, J. M. Stark, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 1
How close are we to personalized mitotane dosing in the treatment of adrenocortical carcinoma? State of the art and future perspectives
Rebecca V. Steenaard, Madeleine H. T. Ettaieb, Thomas Kerkhofs, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 6, pp. 677-683
Closed Access
Page 1

Scroll to top